Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
8.77
-0.02 (-0.23%)
Jun 27, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M